Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,413 | -50,467 | -36,424 | -18,460 | -110,715 |
| Depreciation Amortization | 1,085 | 803 | 539 | 265 | 576 |
| Accounts payable and accrued liabilities | 1,655 | 3,061 | 1,601 | 2,715 | -426 |
| Other Working Capital | 1,724 | 766 | 3,856 | 3,486 | 4,427 |
| Other Operating Activity | 20,368 | 7,791 | 4,258 | 455 | 76,359 |
| Operating Cash Flow | $-54,581 | $-38,046 | $-26,170 | $-11,539 | $-29,779 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -74,033 | 6,095 | -339 | 10,887 | -79,807 |
| PPE Investments | -259 | -177 | 6 | -15 | -42 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 29,371 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3 |
| Investing Cash Flow | $-74,292 | $5,918 | $-333 | $10,872 | $-50,481 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,726 |
| Common Stock Issued | 116,593 | 114,520 | 8,529 | 1,259 | 25,104 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -44 |
| Other Financing Activity | 8,682 | 10,585 | -218 | 0 | 74,525 |
| Financing Cash Flow | $125,275 | $125,105 | $8,311 | $1,259 | $101,311 |
| Beginning Cash Position | 45,897 | 45,897 | 45,897 | 45,897 | 24,846 |
| End Cash Position | 42,299 | 138,875 | 27,704 | 46,489 | 45,897 |
| Net Cash Flow | $-3,598 | $92,978 | $-18,192 | $592 | $21,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,581 | -38,046 | -26,170 | -11,539 | -29,779 |
| Capital Expenditure | -338 | -254 | -69 | -15 | -42 |
| Free Cash Flow | -54,919 | -38,300 | -26,239 | -11,554 | -29,821 |